Clinical Trials Logo

Clinical Trial Summary

This study evaluate clinical efficacy and safety in adult patients administered BriTurn injection or BrisTurn Prefilled injection for reversal of neuromuscular blockade induced by Rocuronium or Vecuronium.


Clinical Trial Description

This study evaluate clinical efficacy and safety in adult patients administered BriTurn injection or BrisTurn Prefilled injection for reversal of neuromuscular blockade induced by Rocuronium or Vecuronium. - Efficacy: Time (minutes) for Train-Of-Four (TOF) ratio to reach 0.9 (90%) - Safety: whether bradycardia and resulting cardiac arrest occur or whether bronchospasm occurs ;


Study Design


Related Conditions & MeSH terms

  • Reversal of Neuromuscular Blockade

NCT number NCT06246331
Study type Observational
Source Hanlim Pharm. Co., Ltd.
Contact Sangseok Lee
Phone +82-2-950-1989
Email s2248@paik.ac.kr
Status Recruiting
Phase
Start date July 21, 2023
Completion date December 31, 2024

See also
  Status Clinical Trial Phase
Not yet recruiting NCT06436768 - Efficacy and Safety of Sugammadex in Thoracoscopy Thymectomy for Chinese Adults With Myasthenia Gravis N/A
Completed NCT03346057 - Safety of Sugammadex for the Reversal of Neuromuscular Blockade in American Society of Anesthesiologists (ASA) Class 3 or 4 Participants (MK-8616-145) Phase 4
Enrolling by invitation NCT05887375 - Sugammadex vs Neostigmine/Glycopyrrolate on Urinary Retention After Spine Surgery Phase 4